Evidence map›Paper›PMID 41420604›Full record

ArticleJournal of medicinal chemistry2026

Enhancing the Predictive Power of Macrocyclic Drug Permeability by Knowledge Distillation from Analogous Pretraining Data.

Yu Zhang, Olli T Pentikäinen

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yu ZhangInstitute of Biomedicine, Integrative Physiology and Pharmacy, University of Turku, FI-20014 Turku, Finland.ORCID 0009-0005-6690-8198
Olli T PentikäinenInstitute of Biomedicine, Integrative Physiology and Pharmacy, University of Turku, FI-20014 Turku, Finland.ORCID 0000-0001-7188-4016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrocyclic drugs offer powerful opportunities for modulating protein-protein interactions, yet their development is limited by poor and unpredictable membrane permeability. Experimental testing is slow, and 3D modeling of macrocycles is computationally demanding due to their large conformational space. To address this, we present Multi_DDPP, a deep learning (DL) model that predicts macrocycle permeability directly from 2D structures. Multi_DDPP employs knowledge distillation to leverage permeability data from multiple cell lines, improving generalizability, and uses a task-specific swing-range strategy to reduce label noise. By integrating diverse molecular representations, including physicochemical descriptors, fingerprints, molecular graphs, and hybrid features, the model outperforms existing ML and DL approaches. Node masking highlights the substructures that contribute most to permeability, and regression extensions incorporating physiological parameters further refine these predictions. Early 2D-based permeability prediction with Multi_DDPP avoids the costly generation of 3D conformers and enables the efficient prioritization of macrocycles with favorable pharmacokinetic potential.

Indexed as

Deep LearningMacrocyclic CompoundsCell Membrane PermeabilityHumansModels, MolecularPermeabilityMacrocyclic Compounds

Identifiers

PMID41420604
PMCPMC12794141

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.